Psychopharmacology 2025
Psychopharmacology Overview
The study of substances that influence brain and behavior.
Psychoactive drugs: Compounds that can induce psychological effects (mood, sensation, thinking, or behavior).
These drugs can be naturally derived or chemically synthesized.
Mechanism of Action: Drugs need to enter the brain to affect neurotransmission.
Importance of Psychopharmacology
Understanding how the brain works, including regions and neurotransmitters.
Insights into psychiatric disorders and underlying brain function changes.
Aiming to develop better drug treatments and understand problematic drug use.
Pharmacokinetics Basics
Study of how the body processes a drug. Key components: Absorption, Distribution, Metabolism, and Elimination (ADME).
Absorption: How a drug enters the bloodstream and reaches its site of action.
Distribution: The spread of a drug throughout the body.
Metabolism: The body’s conversion of a drug into compounds for elimination.
Routes of Drug Administration
General Overview
Drugs can be administered in various ways, often needing lipid-soluble forms to pass biological membranes.
Oral Administration
Most common; needs dissolution and passage through stomach walls for absorption.
Must withstand stomach acids and enzymes.
Factors affecting absorption include the need for taking it with food or water and first-pass metabolism (FPM), where drugs are metabolized in the liver before reaching circulation.
IV Administration
Provides rapid, accurate effects but can be dangerous (especially with street drugs).
More even absorption times with intramuscular injections.
Inhalation
Allows rapid drug absorption through the lungs; effective for drugs like nicotine and THC.
Can damage lung tissue over time.
Transdermal & Intranasal Administration
Transdermal: Administration through skin (e.g., patches).
Intranasal: Direct transport to the brain, bypassing the blood-brain barrier (BB). Effective for rapid action, e.g., cocaine.
Absorption and Distribution in the Body
Drugs enter the bloodstream and reach target areas. Speed depends on the concentration gradient.
Highly perfused areas receive more drug first.
Blood-Brain Barrier (BBB)
A selective barrier that limits substance exchange between blood and the brain.
Large or non-lipid soluble molecules are typically blocked.
Metabolism & Elimination
Drugs are metabolized primarily in the liver.
Water-soluble drugs exit through urine, while fat-soluble drugs convert to water-soluble forms.
Example transformations: Codeine converted to Morphine.
Understanding Drug Half-life
The time required to eliminate 50% of the drug from blood.
Varies per drug; impacts dosing frequency and effects.
Examples:
THC: 3-4 days in fat cells
Cocaine: ~1 hour
Heroin: 3-8 minutes (converted to morphine).
Pharmacodynamics
Examines how drugs affect the body, primarily through neurotransmission.
Agonists enhance neurotransmitter activity; antagonists block or dampen it.
Drug Categories
Psychoactive Drugs:
CNS Stimulants: Amphetamine, Cocaine, Nicotine.
CNS Depressants: Barbiturates, Alcohol, Morphine, Codeine.
Hallucinogens: Mescaline, LSD, Psilocybin.
Psychotherapeutics: Prozac, Thorazine.
Stimulants
Cocaine: Inhibits reuptake of dopamine and norepinephrine.
Amphetamines: Increase dopamine release.
Caffeine: Adenosine antagonist, enhances dopaminergic neurotransmission.
Depressants
Reduce CNS arousal; affect coordination and judgment.
Examples: Alcohol, Benzodiazepines (Xanax, Valium) which influence GABA.
Alcohol progresses through brain regions, causing decision-making impairments and emotional regulation loss.
Opiates and Opioids
Narcotic Analgesics: Reduce pain and have CNS depressant qualities.
Bind to opioid receptors and promote relaxation; examples include Morphine and Codeine.
Risk of addiction and tolerance builds quickly.
Opioid Addiction Mechanism
Activates the mesolimbic reward system, increasing dopamine release and leading to conditioned drug craving.
Drug Action Mechanisms
Direct Agonists: Bind to receptors (e.g., Heroin).
Indirect Agonists: Enhance neurotransmitter actions without direct binding (e.g., Cocaine).
Antagonists: Bind but don't activate receptors, e.g., reversing opioid overdose with Narcan.
The Opioid Crisis
U.S. leads in drug-related deaths; emphasis on opioid-related fatalities and the need for effective treatments.
Hallucinogenic Drugs
Affect perception; include natural and synthetic substances like LSD and Psilocybin.
Mechanisms often unclear; receptor interactions critical for effects.
MDMA
Acts as both stimulant and psychedelic; increases levels of serotonin, dopamine, and norepinephrine.
Risk of depleting serotonin, leading to negative aftereffects.
Treatment of Disorders
Anxiety
Involves multiple neurotransmitters including GABA and serotonin.
Treatment: Benzodiazepines, SSRIs, SNRIs.
Depression
Predicated on monoamine depletion theory with focus on serotonin and norepinephrine.
Treatment: SSRIs, SNRIs, atypical antidepressants, and MAOIs.
Schizophrenia
Characterized by both positive (delusions, hallucinations) and negative symptoms.
Dopamine focus but includes glutamate and GABA interactions.
Treatment: Antipsychotic medications; nuanced based on receptor interactions.
Upcoming Seminars
Announcements of future educational events.
Positives of Pharmacology as Treatment for Depression
Efficacy: Pharmacological treatments, particularly SSRIs and SNRIs, have been shown to effectively alleviate symptoms of depression in many patients.
Rapid Onset: Some medications can provide quicker relief compared to therapy alone, allowing for faster management of severe symptoms.
Neurochemical Targeting: Antidepressants target neurotransmitter imbalances associated with depression (serotonin, norepinephrine), helping to restore mood.
Accessibility: Medications can be more accessible than therapy, especially in areas with limited mental health resources.
Variety of Options: A wide range of antidepressants available allows for personalization of treatment according to the patient's response.
Negatives of Pharmacology as Treatment for Depression
Side Effects: Many antidepressants come with side effects (weight gain, sexual dysfunction, drowsiness, etc.) that may deter patients from continuing treatment.
Dependency and Withdrawal: Some medications can lead to dependency or withdrawal symptoms if stopped abruptly, complicating treatment plans.
Delayed Onset: While some medications work quickly, others can take several weeks to show effects, leaving patients in distress temporarily.
Stigmatization: Patients may face societal stigma for using medication for mental health, potentially affecting their overall treatment experience and willingness to seek help.
Limited Understanding: The effectiveness of pharmacological treatments can vary widely among individuals due to genetic differences in drug metabolism and neurobiology.